Proton pump inhibitors and upper gastrointestinal bleeding;Inhibiteurs de la pompe à protons et hémorragies digestives hautes

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 2, 2005, Pages 137-139

  Lesur, Gilles ^a   Bour, Bruno ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

DRUG USE; ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT CARE; PEPTIC ULCER BLEEDING; PRESCRIPTION; REVIEW; RISK FACTOR; STOMACH PH; STOMACH ULCER; UPPER GASTROINTESTINAL BLEEDING;

EID: 15044363057     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(05)80716-x     Document Type: Review

References (22)

1. Labenz J, Peitz U, Leusing C, Tillenburg B, Blum AL, Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study. Gut 1997;40:36-41.
2. van Rensburg CJ, Hartmann M, Thorpe A, Venter L, Theron I, Luhmann R, et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2635-41.
3. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
4. Barkun A, Sabbah S, Enns R, Armstrong D, Gregor J, Fedorak RN, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004;99:1238-46.
5. Lesur, Bour B, Aegerter P, ANGH. Prise en charge des hémorragies digestives ulcéreuses en France en CHU et en CHG: une enquête nationale de pratique. Gastroenterol Clin Biol 2005;29:140-4.
6. Khuroo MS, Yattoo GN, Javid G, Khan BA, Shah AA, Gulzar GM, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997;336:1054-8.
7. Sung JJ, Chan FK, Lau JY, Yung MY, Leung WK, Wu JC, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003;139:237-43.
8. Javid G, Masoodi I, Zargar SA, Khan BA, Yatoo GN, Shah AH, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111:280-4.
9. Jung HK, Son HY, Jung SA, Yi SY, Yoo K, Kim DY, et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002; 97:1736-40.
10. Udd M, Miettinen P, Palmu A, Heikkinen M, Janatuinen E, Pasanen P, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol 2001;36:1332-8.
11. Barkun A, Racz I, van Rensburg C, Beglinger C, Kupcinskas L, Schaefer-Preuss S. Prevention of peptic ulcer rebleeding using continuous infusion of pantoprazole vs ranitidine: a multicenter, multinational, randomized, double-blind, parallel-group comparison (abstract). Gastroenterology 2004;126:A78.
12. Fausto C, Lucia P, Laura Z, Alberto de G, Tiziana G, Fransesco Di F, et al. Intravenous omeprazole and pantoprazole after endoscopic treatment of bleeding peptic ulcers (abstract). Gastrointest Endosc 2003;57:AB150.
13. Schilling D, Demel A, Nusse T, Weidmann E, Riemann JF. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy 2003; 35:393-6.
14. Erstad BL. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding. Crit Care Med 2004;32:1277-83.
15. Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding. Aliment Pharmacol Ther 2004;20:195-202.
16. Lee KK, You JH, Wong IC, Kwong SK, Lau JY, Chan TY, et al. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointest Endosc 2003;57:160-4.
17. Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Aliment Pharmacol Ther 2004;19:591-600.
18. Spiegel BM, Ofman JJ, Woods K, Vakil NB. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies. Am J Gastroenterol 2003;98:86-97.
19. Enns RA, Gagnon YM, Rioux KP, Levy AR. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2003;17:225-33.
20. Guda NM, Noonan M, Kreiner MJ, Partington S, Vakil N. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol 2004;99:1233-7.
21. Enns R, Andrews CN, Fishman M, Hahn M, Atkinson K, Kwan P, et al. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation. Can J Gastroenterol 2004;18: 567-71.
22. Pfau PR, Cooper GS, Carlson MD, Chak A, Sivak MV, Jr., Gonet JA, et al. Success and shortcomings of a clinical care pathway in the management of acute nonvariceal upper gastrointestinal bleeding. Am J Gastroenterol 2004;99:425-31.